Position
Postdoc
Team
Interferon and antiviral restriction
Contact
email :
Tél : 04 34 35 94 33
Publications
Long, J.S., Giotis, E.S., Moncorgé, O., Frise, R., Mistry, B., James, J., Morisson, M., Iqbal, M., Vignal, A., Skinner, M.A., and Barclay, W.S. (2016). Species difference in ANP32A underlies influenza A virus polymerase host restriction. Nature 529(7584):101-4.
Goujon, C., Moncorgé, O., Bauby, H., Doyle, T., Barclay, W.S., and Malim, M.H. (2014). Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor. Journal of Virology 15;88(16):9017-26.
Cauldwell, A.V., Long, J.S., Moncorgé, O., and Barclay, W.S. (2014). Viral determinants of influenza A virus host range (review). Journal of General Virology. 95(Pt 6):1193-210.
Goujon, C., Moncorgé, O., Bauby, H., Doyle, T., Ward, C.C., Schaller, T., Hué, S., Barclay, W.S., Schulz, R., and Malim, M.H. (2013). Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature. Oct 24;502(7472):559-62.
Long, J.S., Howard, W.A., Núñez, A., Moncorgé, O., Lycett, S., Banks, J., and Barclay, W.S. (2013). The Effect of the PB2 Mutation 627K on Highly Pathogenic H5N1 Avian Influenza Virus Is Dependent on the Virus Lineage. Journal of Virology 87(18):9983-96.
Cauldwell, A.V., Moncorgé, O., and Barclay, W.S. (2013). Unstable polymerase-nucleoprotein interaction is not responsible for avian influenza virus polymerase restriction in human cells. Journal of Virology 87(2):1278-84.
Moncorgé, O., Long, J.S., Cauldwell, A.V., Zhou, H., Lycett, S.J., and Barclay, W.S. (2013). Investigation of influenza virus polymerase activity in pig cells. Journal of Virology 87(1):384-94.
Moncorgé, O., Mura, M., and Barclay, W.S. (2010). Evidence for avian and human host cell factors that affect the activity of influenza virus polymerase. Journal of Virology 84(19):9978-86.
Bickle, M., Dusserre, E., Moncorgé, O., Bottin, H., and Colas, P. (2006). Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures. Nature Protocols 1(3):1066-91.
